Mounjaro generated $3.091 billion, more than triple (216%) the $979.7 million in revenue a year earlier, while Zepbound, the newer of the drugs approved just last November, racked up $1.243 billion
BMJ Open 5(11):e009088
If TrumpRx fails to achieve broad adoption, or if the administrations drug pricing agenda reverses course as presidential executive orders on drug pricing have historically done in litigation the Cost Plus association with TrumpRx becomes a liability rather than an asset
References 1.Tsapas A, Avgerinos I, Karagiannis T, et al
If you are pregnant, nursing, or taking prescription medications, it is always a good idea to consult with your healthcare provider before adding a glutathione drink to your routine
The potential benefits of Sermorelin for healthy aging is in discussed in further detail on the Sermorelin page